Internal Medicine, Pulmonary Disease · Augusta, GA
NPI
1831173426
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1120 15th St
Augusta, GA, 30912
Phone (706) 721-3813
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
1,171 services
Medicare patients, 2024
445
Average age 71
Drug cost, 2024
$10.8M
5,334 prescriptions
Company payments, 2025
$977
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Varsha S Taskar was code 99214 (office e&m - established), 339 times for 214 patients. In total Varsha S Taskar billed 1,171 services in 37 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 339 | 214 | $71.54 | $24K |
| 94729 Pulmonary Function Testing | Facility | 168 | 161 | $6.29 | $1,056 |
| 94010 Pulmonary Function Testing | Facility | 143 | 131 | $5.87 | $839 |
| 94726 Pulmonary Function Testing | Facility | 85 | 84 | $8.30 | $706 |
| 94060 Pulmonary Function Testing | Facility | 78 | 77 | $7.10 | $554 |
| 99213 Office E&M - Established | Facility | 52 | 45 | $47.85 | $2,488 |
| 99232 Hospital E&M - Subsequent | Facility | 46 | 16 | $59.66 | $2,745 |
| 94618 Pulmonary Function Testing | Facility | 43 | 41 | $16.17 | $695 |
| 99233 Hospital E&M - Subsequent | Facility | 31 | 16 | $89.68 | $2,780 |
| 99203 Office E&M - New | Facility | 28 | 28 | $61.21 | $1,714 |
| 94727 Pulmonary Function Testing | Facility | 23 | 23 | $8.95 | $206 |
| 99204 Office E&M - New | Facility | 20 | 20 | $97.34 | $1,947 |
| 95810 Sleep Study | Facility | 18 | 18 | $73.46 | $1,322 |
| 95806 Sleep Study | Facility | 18 | 17 | $24.48 | $441 |
By year: 2022 $60K for 1,599 services; 2023 $60K for 1,464 services; 2024 $49K for 1,171 services.
Medicare prescription drug claims, 2024
In 2024, the drug Varsha S Taskar prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 424 prescriptions and refills. In total Varsha S Taskar wrote 5,334 Medicare prescriptions that cost $10.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 424 | 529 | 147 | $10K |
| Montelukast Sodium Generic | 405 | 750 | 115 | $2,873 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 391 | 493 | 86 | $312K |
| Azithromycin Generic | 351 | 426 | 91 | $4,760 |
| Ofev Nintedanib Esylate | 232 | 238 | 31 | $2.7M |
| Prednisone Generic | 227 | 263 | 86 | $989 |
| Furosemide Generic | 222 | 313 | 60 | $785 |
| Breo Ellipta Fluticasone/Vilanterol | 154 | 168 | 33 | $66K |
| Ambrisentan Generic | 124 | 124 | 15 | $275K |
| Famotidine Generic | 94 | 118 | 22 | $949 |
| Symbicort Budesonide/Formoterol Fumarate | 90 | 113 | 36 | $25K |
| Opsumit Macitentan | 85 | 85 | Under 11 | $1.1M |
| Mycophenolate Mofetil Generic | 85 | 118 | 19 | $12K |
| Eliquis Apixaban | 83 | 87 | 14 | $52K |
| Sildenafil Citrate Generic | 70 | 90 | 17 | $2,827 |
Brand drugs: 2,099 claims; generic drugs: 3,235 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Varsha S Taskar $977 ($977 in general payments such as food, travel and fees) from 15 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $242.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $242 |
| United Therapeutics Corporation UTHR | 2 | $220 |
| ANI Pharmaceuticals, Inc. ANIP | 5 | $88.44 |
| GlaxoSmithKline, LLC. GSK | 5 | $80.3 |
| Genzyme Corporation SNY | 2 | $71.97 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $57.48 |
| Baxter Healthcare BAX | 1 | $44.38 |
| Merck Sharp & Dohme LLC MRK | 2 | $44 |
| Abbvie Inc. ABBV | 2 | $40.06 |
| Alcresta Therapeutics, Inc. | 1 | $29.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.